Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2589_Библиотеки_им_академика_М_И_Перельмана
.pdf
12
ab
https://t.me/medicina_free
1 Retinal Capillary Microaneurysms
Fig. 1.8 A 35-year-old woman with type 2 DM for
10 years from a pre-anti-VEGF era. Had uncontrolled
BSL and Hb 9.1 gm%. Fundus uorescein angiography
revealed multiple microaneurysms; some are encircled
(a). She was advised of multifactorial control of her meta-
for the progression of diabetic retinopathy independent of chronic kidney disease [17, 18]
Reversal of hypoxia by the correction of coexisting anaemia may cause complete disappearance
of MAs [19] (Fig.1.8).
bolic parameters. She was treated with iron supplementation. Over the next 9months, her BSL were controlled,
and the Hb increased to 11.1 gm%. Note the disappearing
microaneurysms (b)
changes in the multiple ways by which the retina
is imaged, termed multimedia imaging.
Exploiting the various reectance properties of
various retinal structures, the scanning laser ophthalmoscope in digital cameras can obtain blue
reectance (for supercial structures like epiretinal membranes), green reectance (for blood
1.10 Imaging ofRetinal Capillary
Microaneurysms
vessels, MAs, RNFL and exudates), and nearinfrared reectance (for deeper retina and choroi-
dal structures) images to highlight retinal
Fundus imaging is fundamental in tele-screening
strategies for the early detection of diabetic retinopathy. The fundus images also serve as a document for future changes in the retina, determine
the need for therapeutic interventions, and assess
the outcome of those interventions. In the past,
30° standard 7-eld, colour lm-based fundus
photography through a dilated pupil was done to
document retinal diseases and objectively
document the effect of the therapeutic interventions on retinal pathology, including MAs. The
structures located in the different layers of the
retina. Besides, these systems now obtain a wide
angle (retinal eld of view including vortex vein
ampulla) or ultra-wide (includes retina eld of
view anterior to the entry of vortex veins) image
of the entire retina (~200°) in a single exposure.
The need for stereoscopic retina imaging is obvi-
ated by using optical coherence tomography
(OCT) for microstructural retina (1–3 μm axial
resolution) imaging and visualizing the cross-
sectional or enface details.
seven elds included the one centered on the
optic disc, macula, and temporal to the macula.
Four images were taken tangentially to lines
forming a cross passing at the upper and lower
1.10.1 Imaging ofRetinal Capillary
Microaneurysms: Morphology
poles of the optic disc. Non-simultaneous stereoscopic pictures were taken of all the elds. In
recent years, there have been revolutionary
Using adaptive optics scanning laser ophthalmoscope (AOSLO) at least six morphological types

1.10 Imaging ofRetinal Capillary Microaneurysms
https://t.me/medicina_free
13
of MAs are recognized. These are focal bulging,
saccular, fusiform, mixed saccular/fusiform,
pedunculated, and irregularly shaped [20]. The
morphological shape rather than the size of the
MAs is responsible for leakage. The irregular,
mixed type, and fusiform are more likely to leak
than the saccular and pedunculated MAs [21].
Moreover, saccular MAs are more likely to be
thrombosed than fusiform MAs [22]. Simulation
studies have shown that reduced inlet velocity of
the feeding vessel of the saccular MAs leads to
increased adherence of the platelets to the aneurysmal wall where the blood is more stagnant
and initiates thrombus formation. Reduced bold
ow velocity may also lead to thrombus formation in some fusiform MAs [17, 18]. It may be
noted that before the development of retinopathy, the blood ow velocity in type 1 DM is
reduced and is dependent on the blood glucose
levels, but with the development of non-proliferative diabetic retinopathy there is an increase in
the ow velocity [23]. It is likely that this
increase in ow velocity may be mediated
through vascular endothelial growth factor
(VEGF) [17, 18, 24].
1.10.2 Imaging ofRetinal Capillary
Microaneurysms: OCT
On optical coherence tomography (OCT), MAs
show either a complete, incomplete, or no ring.
Compared to those with no or incomplete
rings, MAs with complete rings are less likely
to be associated with cystic spaces in the retina. The complete ring likely indicates a thickened and hyalinized basement membrane.
Hyperreectivity in the MAs indicates the
presence of cellular elements and is often seen
in those without rings [25].
1.10.3 Imaging ofRetinal Capillary
Microaneurysms: OCTA
Optical coherence tomography angiography
(OCTA) allows 3-D enface visualization of the
various segmented layers of the retina with a
caveat that all microaneurysms may not be visible on OCTA [26]. On a 3-D rotational OCTA,
most MAs are fusiform in shape and seem to
arise from the DCP in the inner nuclear layer
(Fig.1.9). Some of these are also present in the
SCP and on the capillaries connecting the SCP
and the DCP. MAs are also seen in the outer
plexiform layer [27, 28]. Most MAs are associated with two vessels originating in the DCP and,
less commonly, from the SCP.Those arising from
the DCP are in the inner nuclear layer, those from
the SCP occupy the ganglion cell layer, and others may be seen in the outer plexiform layer and
rarely in the outer nuclear layer [27].
In OCTA, two reectivity patterns are discernible in the MAs, hyporeective and hyperreective. Hyporeective MAs are unlikely to be
visible on OCTA because of a very slow blood
ow or thrombosis, while the hyperreective
MAs are visible due to increased blood ow in
these MAs which may damage the wall of the
MAs, causing extravasation and retinal thickening [28] (Fig.1.10).
The last few years have seen a very aggressive
application of articial intelligence using deep
learning algorithms for the automated detection
of the earliest diabetic retinopathy changes,
namely, the MAs and dot haemorrhages [29].

14
https://t.me/medicina_free
1 Retinal Capillary Microaneurysms
a
b
cd e f
Fig. 1.9 Colour Fundus photograph of the left eye (a)
showing moderate non-proliferative diabetic retinopathy
(microaneurysms, retinal haemorrhages and cotton wool
spots). Fluorescein angiogram (b) showing leaking microaneurysms (yellow arrows) and retinal haemorrhages. The
bottom panel shows the OCT angiography (macular scan
3.00×3.00 mm scan) with microaneurysms seen in the
supercial capillary plexus (SCP) (yellow arrows) (c), as
well as deep capillary plexus (DCP) as fusiform dilatations (yellow arrows) (d). The microaneurysms are absent
in the outer retina (e) and choriocapillaris (f) layers

ef
1.11 Other Causes ofRetinal Capillary Microaneurysms
https://t.me/medicina_free
ab
cd
15
Fig. 1.10 Colour Fundus photograph of the right eye (a)
showing moderate NPDR (microaneurysms, retinal haemorrhages and cotton wool spots). Fluorescein angiogram
(b) showing leaking microaneurysms, some of which are
visible (blue arrows) on OCT angiography (bottom panel)
1.11 Other Causes ofRetinal
Capillary Microaneurysms
Retinal microaneurysms are formed in response
to hypoxia of the retina. In patients with hypertensive retinopathy, microaneurysms are seen
surrounding cotton-wool spots formed by the
occlusion of precapillary arterioles. These microaneurysms last only a few weeks and disappear
with the disappearance of the cotton wool spots.
Besides diabetes and hypertension, microaneurysms may be seen in carotid atherosclerosis
(carotid insufciency). In contrast to diabetes,
where MAs are predominantly seen in the posterior pole, in carotid insufciency, MAs are seen
in the retinal periphery. Likewise, these may be
seen in Takayasu’s arteritis (TA) if the arteries
involve the common or the internal carotid artery
(Figs.1.11 and 1.12). In the latter, MAs are seen
in supercial capillary plexus (SCP) (c) or deep capillary
plexus (DCP) (d). In contrast, some on FFA (yellow
arrows) are not visible on OCT angiography. The microaneurysms are not seen in the outer retina (e) and choriocapillaris (f) layers
all over the retina and are accompanied by a
cattle- trucking of the blood cells in both retinal
arterioles and the veins. Low intraocular pressure
can be an additional clue to diagnosing TA in
these two situations. Patients may also complain
of dizziness on suddenly getting up (Fig.1.13).
Microaneurysms may also be seen in longstanding branch retinal vein occlusion (BRVO)
(Fig. 1.14) and central retinal vein occlusion
(CRVO). These are also seen in congenital retinal
vasculature abnormalities such as Coats’ disease
which mostly affects young boys’ left eye. Large
microaneurysm dilatations on telangiectatic retinal vessels characterize the latter. These profusely leak uid and lipoproteins, forming
massive deposits of hard exudates. Limited MAs
are also seen in type 1 macular telangiectasia
(Mac Tel type 1). The formation of MAs also
characterizes radiation retinopathy.

16
https://t.me/medicina_free
1 Retinal Capillary Microaneurysms
ab
c
Fig. 1.11 A 28-year-old woman complained of giddiness
on standing. Brachial pulse was absent. She had bilateral
symmetrical changes. The right showed venous fullness
with few visible microaneurysms (a). On FFA, there was
a remarkable delay in the perfusion of the dye in the retinal arterioles with several microaneurysms (b), which are
absent in the macula but prominent along the vessels.
Cattle trucking can be seen in the major veins (c and d).
She also complained of giddiness which recovered on
lowering of head. Her physical exam was signicant for
d
absent radial and brachial pulses. On ocular examination
she had visual acuity of 6/36 OU.Her intraocular pressures were 6 and 7mm in the right and left eye, respectively. There were no iris neovessels. Pupil reactions were
sluggish. She underwent CT angio of arch of aorta and its
branches was suggestive of Type 4 Takayasu arteritis
involving the ascending aorta, arch of aorta, descending
aorta, left pulmonary artery, bilateral common carotid
artery, brachiocephalic trunk, bilateral subclavian and
axillary arteries

ab
1.11 Other Causes ofRetinal Capillary Microaneurysms
https://t.me/medicina_free
c
17
Fig. 1.12 CT angio of the same patient shown in Fig.1.11, shows involvement of ascending aorta, arch of aorta, left
pulmonary artery, bilateral common carotid arteries, brachiocephalic trunk, bilateral subclavian and axillary arteries

18
ab
https://t.me/medicina_free
1 Retinal Capillary Microaneurysms
cd
Fig. 1.13 A 43-year-old female with a history of upper
limbs claudication and syncope show (a) attenuation of
both common carotid arteries-CCA (right > left) [thin
arrow—right CCA, thick arrow—left CCA], (b) attenuated osteo-proximal left subclavian (thin arrows) and (c)
attenuated osteo-proximal right subclavian (thin arrows)
arteries on reconstructed coronal CT angiography images.
Note prominent collateral in (b) and circumferential
mural thickening of the arch of the aorta (thick arrow in
c). Axial image (d) shows circumferential symmetric
mural thickening with attenuation of the calibre of the brachiocephalic trunk, left CAA and left subclavian arteries.
Images courtesy of DR Manphool Singhal. Department of
Radiodiagnosis, Post Graduate Institute of Medical
Education and Research, Chandigarh. India

ab
1.12 Signicance ofRetinal Capillary Microaneurysms
https://t.me/medicina_free
19
Fig. 1.14 Colour fundus photograph (a) of the right eye
of a patient with macular branch retinal vein occlusion
(BRVO), showing retinal haemorrhages (black arrows)
1.12 Signicance ofRetinal
Capillary Microaneurysms
and hard exudates (blue arrow) in the macula. Fundus
uorescein angiography (b) showed microaneurysms
(yellow arrows) that were not visible clinically
5. All three microvascular complications of diabetes, namely, retinopathy, nephropathy, and
peripheral neuropathy, are intimately related.
1. Sighting of retinal MAs in patients with diabetes indicates that the patients have had outof- range glycemic control for at least 5years.
It should be noted that in patients who have
the onset of type 1 diabetes before puberty,
MAs are not seen till the onset of puberty.
2. Besides being now the leading cause of blindness, the presence of MAs in patients with
diabetes (diabetic retinopathy) should prompt
a search for associated diabetic nephropathy.
Both are microangiopathy manifestations of
long-standing diabetes. Diabetic nephropathy
is now the leading cause of end-stage renal
disease requiring renal replacement therapy.
Diabetic retinopathy is an independent risk
factor for the outcome of diabetic nephropathy [30].
3. In the elderly population, retinal MAs are an
independent risk factor for the progressive
worsening of renal functions [31].
4. Patients with impaired glucose tolerance or
impaired fasting glucose who have peripheral
neuropathy are four times more likely to have
retinopathy and twice more often albuminuria
than those with no peripheral neuropathy [32].
Detecting retinopathy should lead to a search
for peripheral neuropathy and peripheral arterial disease (PAD). Diabetes is a major risk
factor for the acceleration of atherosclerotic
PAD. Coupled with diabetic peripheral polyneuropathy, it is the leading cause of amputation of limbs/toes/feet [33].
6. Irrespective of the associated diabetes or
hypertension, MAs and dot haemorrhages are
more likely to be seen in patients with acute
coronary syndrome than stable angina. Thus,
a useful adjunct in risk assessment requiring a
closer watch [34].
7. There is mounting evidence that retinal microvascular lesions, including MAs/Ha, irrespective of known risk factors, diabetes,
hypertension, smoking etc., are markers of
subclinical microangiopathy in the brain and
can be used to predict future events like stroke
[35].
8. Increasing the number of diabetic microvascular complications (retinopathy, nephropathy,
and peripheral neuropathy) is related to an
increased risk of cardiovascular events and
all-cause mortality in type 1 diabetes [36].

20
https://t.me/medicina_free
1 Retinal Capillary Microaneurysms
9. Diffusely scattered MAs indicate the presence
of an underlying systemic atherosclerotic disease if it involves the internal carotid artery in
the elderly or Takayasu’s arteritis in younger
patients.
References
1. American Diabetes Association. Standards of Medical
Care in Diabetes—2022 abridged for primary care
providers. Clin Diabetes. 2022;40(1):10–38. https://
doi.org/10.2337/cd22- as01. PMID: 35221470;
PMCID: PMC8865785.
2. Omri S, Omri B, Savoldelli M, Jonet L, ThillayeGoldenberg B, Thuret G, Gain P, Jeanny JC, Crisanti P,
Behar-Cohen F.The outer limiting membrane (OLM)
revisited: clinical implications. Clin Ophthalmol.
2010;4:183–95. https://doi.org/10.2147/opth.s5901.
PMID: 20463783; PMCID: PMC2861922.
3. Lechner J, O’Leary OE, Stitt AW.The pathology associated with diabetic retinopathy. Vis Res. 2017;139:7–
14. https://doi.org/10.1016/j.visres.2017.04.003.
Epub 2017 Apr 29. PMID: 28412095.
4. Rodrigues M, Xin X, Jee K, Babapoor-Farrokhran S,
Kashiwabuchi F, Ma T, Bhutto I, Hassan SJ, Daoud
Y, Baranano D, Solomon S, Lutty G, Semenza GL,
Montaner S, Sodhi A. VEGF secreted by hypoxic
Müller cells induces MMP-2 expression and activity
in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes.
2013;62(11):3863–73. https://doi.org/10.2337/db13-
0014. Epub 2013 Jul 24. PMID: 23884892; PMCID:
PMC3806594.
5. Dollery CT, Hodge JV, Engel M. Studies of the
retinal circulation with ourescein. Br Med J.
1962;2(5314):1210–5. https://doi.org/10.1136/
bmj.2.5314.1210. PMID: 14028474; PMCID:
PMC1926224.
6. Novotny HR, Alvis DL. A method of photographing uorescence in circulating blood in the human
retina. Circulation. 1961;24:82–6. https://doi.
org/10.1161/01.cir.24.1.82. PMID: 13729802.
7. Hill DW, Dollery CT, Mailer CM, Oakley NW,
Ramalho PS. Arterial uorescein studies in diabetic
retinopathy. Proc R Soc Med. 1965;58(7):535–7.
PMID: 19994430; PMCID: PMC1898598.
8. Kohner EM, Dollery CT, Paterson JW, Oakley NW.
Arterial uorescein studies in diabetic retinopathy.
Diabetes 1967;16(1):1–10. https://doi.org/10.2337/
diab.16.1.1. PMID: 6015679.
9. Munuera-Gifre E, Saez M, Juvinyà-Canals D,
Rodríguez-Poncelas A, Barrot-de-la-Puente JF,
Franch-Nadal J, Romero-Aroca P, Barceló MA, Collde-Tuero G. Analysis of the location of retinal lesions
in central retinographies of patients with type 2 diabe-
tes. Acta Ophthalmol. 2020;98(1):e13–21. https://doi.
org/10.1111/aos.14223. Epub 2019 Aug 30. PMID:
31469507.
10. Kohner EM, Sleightholm M. Does microaneurysm
count reect severity of early diabetic retinopathy? Ophthalmology. 1986;93(5):586–9. https://
doi.org/10.1016/s0161- 6420(86)33692- 3. PMID:
3725317.
11. Klein R, Meuer SM, Moss SE, Klein BE. Retinal
microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol.
1995;113(11):1386–91. https://doi.org/10.1001/archo
pht.1995.01100110046024. PMID: 7487599.
12. Silva PS, El-Rami H, Barham R, Gupta A, Fleming
A, van Hemert J, Cavallerano JD, Sun JK, Aiello
LP. Hemorrhage and/or microaneurysm severity and count in ultrawide eld images and early
treatment diabetic retinopathy study photography.
Ophthalmology. 2017;124(7):970–6. https://doi.
org/10.1016/j.ophtha.2017.02.012. Epub 2017 Mar
20. PMID: 28336057.
13. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec
FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis
AP. Intravitreous injections of vascular endothelial
growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology.
1996;103(11):1820–8. https://doi.org/10.1016/s0161-
6420(96)30420- x. PMID: 8942877.
14. Couturier A, Rey PA, Erginay A, Lavia C, Bonnin S,
Dupas B, Gaudric A, Tadayoni R. Wideeld OCTangiography and uorescein angiography assessments
of nonperfusion in diabetic retinopathy and edema
treated with anti-vascular endothelial growth factor.
Ophthalmology. 2019;126(12):1685–94. https://doi.
org/10.1016/j.ophtha.2019.06.022. Epub 2019 Jun
26. PMID: 31383483.
15. Leicht SF, Kernt M, Neubauer A, Wolf A, Oliveira
CM, Ulbig M, Haritoglou C. Microaneurysm turnover in diabetic retinopathy assessed by automated
RetmarkerDR image analysis—potential role as
biomarker of response to ranibizumab treatment.
Ophthalmologica. 2014;231(4):198–203. https://doi.
org/10.1159/000357505. Epub 2014 Mar 19. PMID:
24662930.
16. Sugimoto M, Ichio A, Mochida D, Tenma Y, Miyata
R, Matsubara H, Kondo M.Multiple effects of intravitreal Aibercept on microvascular regression in eyes
with diabetic macular edema. Ophthalmol Retina.
2019;3(12):1067–75. https://doi.org/10.1016/j.
oret.2019.06.005. Epub 2019 Jun 15. PMID:
31446029.
17. Li H, Sampani K, Zheng X, Papageorgiou DP, Yazdani
A, Bernabeu MO, Karniadakis GE, Sun JK.Predictive
modelling of thrombus formation in diabetic retinal
microaneurysms. R Soc Open Sci. 2020a;7(8):201102.
https://doi.org/10.1098/rsos.201102. PMID:
32968536; PMCID: PMC7481715.
18. Li Y, Yu Y, VanderBeek BL.Anaemia and the risk of
progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy. Eye

References
https://t.me/medicina_free
21
(Lond). 2020b;34(5):934–41. https://doi.org/10.1038/
s41433- 019- 0617- 6. Epub 2019 Oct 4. PMID:
31586167; PMCID: PMC7182576.
19. Singh R, Gupta V, Gupta A, Bhansali A.Spontaneous
closure of microaneurysms in diabetic retinopathy with treatment of co-existing anaemia. Br
J Ophthalmol. 2005;89(2):248–9. https://doi.
org/10.1136/bjo.2004.050252. PMID: 15665369;
PMCID: PMC1772514.
20. Dubow M, Pinhas A, Shah N, Cooper RF, Gan A,
Gentile RC, Hendrix V, Sulai YN, Carroll J, Chui TY,
Walsh JB, Weitz R, Dubra A, Rosen RB.Classication
of human retinal microaneurysms using adaptive optics
scanning light ophthalmoscope uorescein angiography. Invest Ophthalmol Vis Sci. 2014;55(3):1299–
309. https://doi.org/10.1167/iovs.13- 13122. PMID:
24425852; PMCID: PMC3943418.
21. Schreur V, Domanian A, Liefers B, Venhuizen FG,
Klevering BJ, Hoyng CB, de Jong EK, Theelen
T. Morphological and topographical appearance of
microaneurysms on optical coherence tomography
angiography. Br J Ophthalmol. 2018:bjophthalmol2018- 312258. https://doi.org/10.1136/bjophthalmol-
2018- 312258. Epub ahead of print. PMID: 29925511.
22. Bernabeu MO, Lu Y, Abu-Qamar O, Aiello LP, Sun
JK. Estimation of diabetic retinal microaneurysm
perfusion parameters based on computational uid
dynamics modeling of adaptive optics scanning
laser ophthalmoscopy. Front Physiol. 2018;9:989.
https://doi.org/10.3389/fphys.2018.00989. PMID:
30245632; PMCID: PMC6137139.
23. Bursell SE, Clermont AC, Kinsley BT, Simonson DC,
Aiello LM, Wolpert HA. Retinal blood ow changes
in patients with insulin-dependent diabetes mellitus
and no diabetic retinopathy. Invest Ophthalmol Vis
Sci. 1996;37(5):886–97. PMID: 8603873.
24. Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell
SE.Vascular endothelial growth factor and severity of
nonproliferative diabetic retinopathy mediate retinal
hemodynamics in vivo: a potential role for vascular
endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol.
1997;124(4):433–46. https://doi.org/10.1016/s0002-
9394(14)70860- 8. PMID: 9323935.
25. Horii T, Murakami T, Nishijima K, Sakamoto A, Ota
M, Yoshimura N. Optical coherence tomographic
characteristics of microaneurysms in diabetic retinopathy. Am J Ophthalmol. 2010;150(6):840–8. https://
doi.org/10.1016/j.ajo.2010.06.015. Epub 2010 Sep
19. PMID: 20855054.
26. Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal
vascular layers imaged by uorescein angiography
and optical coherence tomography angiography.
JAMA Ophthalmol. 2015;133(1):45–50. https://doi.
org/10.1001/jamaophthalmol.2014.3616. PMID:
25317632.
27. Borrelli E, Sacconi R, Brambati M, Bandello F,
Querques G. In vivo rotational three-dimensional
OCTA analysis of microaneurysms in the human diabetic retina. Sci Rep. 2019;9(1):16789. https://doi.
org/10.1038/s41598- 019- 53357- 1. PMID: 31728070;
PMCID: PMC6856183.
28. Querques G, Borrelli E, Battista M, Sacconi R,
Bandello F. Optical coherence tomography angiography in diabetes: focus on microaneurysms. Eye
(Lond). 2021;35(1):142–8. https://doi.org/10.1038/
s41433- 020- 01173- 7. Epub 2020 Sep 4. PMID:
32887935; PMCID: PMC78526765.
29. Rageh A, Ashraf M, Fleming A, Silva PS.Automated
microaneurysm counts on ultrawide eld color and
uorescein angiography images. Semin Ophthalmol.
2021;36(4):315–21. https://doi.org/10.1080/0882
0538.2021.1897852. Epub 2021 Mar 28. PMID:
33779483.
30. Zhang J, Wang Y, Li L, Zhang R, Guo R, Li H, Han
Q, Teng G, Liu F. Diabetic retinopathy may predict
the renal outcomes of patients with diabetic nephropathy. Ren Fail. 2018;40(1):243–51. https://doi.org/1
0.1080/0886022X.2018.1456453. PMID: 29633887;
PMCID: PMC6014304.
31. Edwards MS, Wilson DB, Craven TE, Stafford J,
Fried LF, Wong TY, Klein R, Burke GL, Hansen
KJ. Associations between retinal microvascular
abnormalities and declining renal function in the
elderly population: the cardiovascular health study.
Am J Kidney Dis. 2005;46(2):214–24. https://doi.
org/10.1053/j.ajkd.2005.05.005. PMID: 16112039.
32. Barr EL, Wong TY, Tapp RJ, Harper CA, Zimmet PZ,
Atkins R, Shaw JE, AusDiab Steering Committee.
Is peripheral neuropathy associated with retinopathy
and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab. Diabetes
Care. 2006;29(5):1114–6. https://doi.org/10.2337/
diacare.2951114. PMID: 16644648.
33. Thiruvoipati T, Kielhorn CE, Armstrong EJ.Peripheral
artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes.
2015;6(7):961–9. https://doi.org/10.4239/wjd.
v6.i7.961. PMID: 26185603; PMCID: PMC4499529.
34. Kralev S, Zimmerer E, Buchholz P, Lin J,
Economopoulou M, Lang S, Kälsch T, Süselbeck
T, Hammes HP. Microvascular retinal changes in
patients presenting with acute coronary syndromes.
Microvasc Res. 2010;79(2):150–3. https://doi.
org/10.1016/j.mvr.2009.12.007. Epub 2010 Jan 4.
PMID: 20053365.
35. Wong TY.Is retinal photography useful in the measurement of stroke risk? Lancet Neurol. 2004;3(3):179–
83. https://doi.org/10.1016/s1474- 4422(04)00682- 9.
PMID: 15029894.
36. Garofolo M, Gualdani E, Giannarelli R, Aragona
M, Campi F, Lucchesi D, Daniele G, Miccoli R,
Francesconi P, Del Prato S, Penno G.Microvascular
complications burden (nephropathy, retinopathy and
peripheral polyneuropathy) affects risk of major
vascular events and all-cause mortality in type 1
diabetes: a 10-year follow-up study. Cardiovasc
Diabetol. 2019;18(1):159. https://doi.org/10.1186/
s12933- 019- 0961- 7. PMID: 31733651; PMCID:
PMC6858978.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
